Expression, purification, and membrane reconstitution of a CD4 fragment comprising the transmembrane and cytoplasmic domains of the receptor

Protein Expression and Purification

Volumn 55, Issue 1, 2007, Pages 198-207

  Wittlich, Marc ^a,b   Wiesehan, Katja ^b   Koenig, Bernd W ^a,b   Willbold, Dieter ^a,b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

CD4; HIV 1; Membrane protein; NMR spectroscopy; Ubiquitin fusion system

Indexed keywords

CD4 ANTIGEN; LIPOSOME; RECOMBINANT PROTEIN; SYNTHETIC DNA; VPU PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BIOSYNTHESIS; CELL MEMBRANE; CHEMISTRY; ESCHERICHIA COLI; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; NUCLEAR MAGNETIC RESONANCE; PROTEIN TERTIARY STRUCTURE;

AMINO ACID SEQUENCE; ANTIGENS, CD4; CELL MEMBRANE; ESCHERICHIA COLI; GENE PRODUCTS, VPU; GENES, SYNTHETIC; HUMANS; LIPOSOMES; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS;

ESCHERICHIA COLI; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 34547919582     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2007.05.007     Document Type: Article

References (56)

1. Koenig B.W., Rogowski M., and Louis J.M. A rapid method to attain isotope labeled small soluble peptides for NMR studies. J. Biomol. NMR 26 (2003) 193-202
2. Staley J.P., and Kim P.S. Formation of a native-like subdomain in a partially folded intermediate of bovine pancreatic trypsin inhibitor. Protein Sci. 3 (1994) 1822-1832
3. Marassi F.M., Ma C., Gratkowski H., Straus S.K., Strebel K., Oblatt-Montal M., Montal M., and Opella S.J. Correlation of the structural and functional domains in the membrane protein Vpu from HIV-1. Proc. Natl. Acad. Sci. USA 96 (1999) 14336-14341
4. Ma C., Marassi F.M., Jones D.H., Straus S.K., Bour S., Strebel K., Schubert U., Oblatt-Montal M., Montal M., and Opella S.J. Expression, purification, and activities of full-length and truncated versions of the integral membrane protein Vpu from HIV-1. Protein Sci. 11 (2002) 546-557
5. Xie X.Q., Zhao J., and Zheng H. Expression, purification, and isotope labeling of cannabinoid CB2 receptor fragment, CB2(180-233). Protein Expr. Purif. 38 (2004) 61-68
6. Mesleh M.F., Lee S., Veglia G., Thiriot D.S., Marassi F.M., and Opella S.J. Dipolar waves map the structure and topology of helices in membrane proteins. J. Am. Chem. Soc. 125 (2003) 8928-8935
7. Yao Q., Bevan J.L., Weaver R.F., and Bigelow D.J. Purification of porcine phospholamban expressed in Escherichia coli. Protein Expr. Purif. 8 (1996) 463-468
8. Park S.H., Mrse A.A., Nevzorov A.A., Mesleh M.F., Oblatt-Montal M., Montal M., and Opella S.J. Three-dimensional structure of the channel-forming trans-membrane domain of virus protein "u" (Vpu) from HIV-1. J. Mol. Biol. 333 (2003) 409-424
9. Kuliopulos A., and Walsh C.T. Production, purification, and cleavage of tandem repeats of recombinant peptides. J. Am. Chem. Soc. 116 (1994) 4599-4607
10. Buck B., Zamoon J., Kirby T.L., DeSilva T.M., Karim C., Thomas D., and Veglia G. Overexpression, purification, and characterization of recombinant Ca-ATPase regulators for high-resolution solution and solid-state NMR studies. Protein Expr. Purif. 30 (2003) 253-261
11. Eliseev R., Alexandrov A., and Gunter T. High-yield expression and purification of p18 form of Bax as an MBP-fusion protein. Protein Expr. Purif. 35 (2004) 206-209
12. Davis G.D., Elisee C., Newham D.M., and Harrison R.G. New fusion protein systems designed to give soluble expression in Escherichia coli. Biotechnol. Bioeng. 65 (1999) 382-388
13. Zhang Y.B., Howitt J., McCorkle S., Lawrence P., Springer K., and Freimuth P. Protein aggregation during overexpression limited by peptide extensions with large net negative charge. Protein Expr. Purif. 36 (2004) 207-216
14. Miroux B., and Walker J.E. Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels. J. Mol. Biol. 260 (1996) 289-298
15. Arechaga I., Miroux B., Karrasch S., Huijbregts R., De Kruijff B., Runswick M.J., and Walker J.E. Characterisation of new intracellular membranes in Escherichia coli accompanying large scale over-production of the b subunit of F(1)F(0) ATP synthase. FEBS Lett. 482 (2000) 215-219
16. Clark S.J., Jefferies W.A., Barclay A.N., Gagnon J., and Williams A.F. Peptide and nucleotide sequences of rat CD4 (W3/25) antigen: evidence for derivation from a structure with four immunoglobulin-related domains. Proc. Natl. Acad. Sci. USA 84 (1987) 1649-1653
17. Levesque K., Finzi A., Binette J., and Cohen E.A. Role of CD4 receptor down-regulation during HIV-1 infection. Curr. HIV. Res. 2 (2004) 51-59
18. Shin J., Doyle C., Yang Z., Kappes D., and Strominger J.L. Structural features of the cytoplasmic region of CD4 required for internalization. EMBO J. 9 (1990) 425-434
19. Lenburg M.E., and Landau N.R. Vpu-induced degradation of CD4: requirement for specific amino acid residues in the cytoplasmic domain of CD4. J. Virol. 67 (1993) 7238-7245
20. Vincent M.J., Raja N.U., and Jabbar M.A. Human immunodeficiency virus type 1 Vpu protein induces degradation of chimeric envelope glycoproteins bearing the cytoplasmic and anchor domains of CD4: role of the cytoplasmic domain in Vpu-induced degradation in the endoplasmic reticulum. J. Virol. 67 (1993) 5538-5549
21. Chen M.Y., Maldarelli F., Karczewski M.K., Willey R.L., and Strebel K. Human immunodeficiency virus type 1 Vpu protein induces degradation of CD4 in vitro: the cytoplasmic domain of CD4 contributes to Vpu sensitivity. J. Virol. 67 (1993) 3877-3884
22. Aiken C., Konner J., Landau N.R., Lenburg M.E., and Trono D. Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76 (1994) 853-864
23. Anderson S.J., Lenburg M., Landau N.R., and Garcia J.V. The cytoplasmic domain of CD4 is sufficient for its down-regulation from the cell surface by human immunodeficiency virus type 1 Nef. J. Virol. 68 (1994) 3092-3101
24. Salghetti S., Mariani R., and Skowronski J. Human immunodeficiency virus type 1 Nef and p56lck protein-tyrosine kinase interact with a common element in CD4 cytoplasmic tail. Proc. Natl. Acad. Sci. USA 92 (1995) 349-353
25. Grzesiek S., Stahl S.J., Wingfield P.T., and Bax A. The CD4 determinant for downregulation by HIV-1 Nef directly binds to Nef. Mapping of the Nef binding surface by NMR. Biochemistry 35 (1996) 10256-10261
26. Grzesiek S., Bax A., Clore G.M., Gronenborn A.M., Hu J.S., Kaufman J., Palmer I., Stahl S.J., and Wingfield P.T. The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase. Nat. Struct. Biol. 3 (1996) 340-345
27. Willbold D., and Rosch P. Solution structure of the human CD4 (403-419) receptor peptide. J. Biomed. Sci. 3 (1996) 435-441
28. Wray V., Mertins D., Kiess M., Henklein P., Trowitzsch-Kienast W., and Schubert U. Solution structure of the cytoplasmic domain of the human CD4 glycoprotein by CD and 1H NMR spectroscopy: implications for biological functions. Biochemistry 37 (1998) 8527-8538
29. Kim P.W., Sun Z.Y., Blacklow S.C., Wagner G., and Eck M.J. A zinc clasp structure tethers Lck to T cell coreceptors CD4 and CD8. Science 301 (2003) 1725-1728
30. Kohno T., Kusunoki H., Sato K., and Wakamatsu K. A new general method for the biosynthesis of stable isotope-enriched peptides using a decahistidine-tagged ubiquitin fusion system: an application to the production of mastoparan-X uniformly enriched with 15N and 15N/13C. J. Biomol. NMR 12 (1998) 109-121
31. Sambrook J., and Russell D.W. Molecular Cloning: A Laboratory Manual (2001), Cold Spring Harbor Laboratory Press, Cold Spring Harbor
32. Wimley W.C., and White S.H. Quantitation of electrostatic and hydrophobic membrane interactions by equilibrium dialysis and reverse-phase HPLC. Anal. Biochem. 213 (1993) 213-217
33. Buser C.A., and McLaughlin S. Ultracentrifugation technique for measuring the binding of peptides and proteins to sucrose-loaded phospholipid vesicles. Methods Mol. Biol. 84 (1998) 267-281
34. Koenig B.W., and Gawrisch K. Specific volumes of unsaturated phosphatidylcholines in the liquid crystalline lamellar phase. Biochim. Biophys. Acta 1715 (2005) 65-70
35. Kusunoki H., Wakamatsu K., Sato K., Miyazawa T., and Kohno T. G protein-bound conformation of mastoparan-X: heteronuclear multidimensional transferred nuclear overhauser effect analysis of peptide uniformly enriched with 13C and 15N. Biochemistry 37 (1998) 4782-4790
36. Bauer F., Hofinger E., Hoffmann S., Rosch P., Schweimer K., and Sticht H. Characterization of Lck-binding elements in the herpesviral regulatory Tip protein. Biochemistry 43 (2004) 14932-14939
37. Bayer R., and Feigenson G.W. Reconstitution of M13 bacteriophage coat protein. A new strategy to analyze configuration of the protein in the membrane. Biochim. Biophys. Acta 815 (1985) 369-379
38. Opella S.J., Ma C., and Marassi F.M. Nuclear magnetic resonance of membrane-associated peptides and proteins. Methods Enzymol. 339 (2001) 285-313
39. Bour S., Schubert U., and Strebel K. The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradation. J. Virol. 69 (1995) 1510-1520
40. Margottin F., Benichou S., Durand H., Richard V., Liu L.X., Gomas E., and Benarous R. Interaction between the cytoplasmic domains of HIV-1 Vpu and CD4: role of Vpu residues involved in CD4 interaction and in vitro CD4 degradation. Virology 223 (1996) 381-386
41. Tiganos E., Yao X.J., Friborg J., Daniel N., and Cohen E.A. Putative alpha-helical structures in the human immunodeficiency virus type 1 Vpu protein and CD4 are involved in binding and degradation of the CD4 molecule. J. Virol. 71 (1997) 4452-4460
42. Willbold D., Hoffmann S., and Rosch P. Secondary structure and tertiary fold of the human immunodeficiency virus protein U (Vpu) cytoplasmic domain in solution. Eur. J. Biochem. 245 (1997) 581-588
43. 2O. Chem. Phys. Lipids 61 (1992) 265-270
44. Greenberg M.E., Bronson S., Lock M., Neumann M., Pavlakis G.N., and Skowronski J. Co-localization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 down-regulation. EMBO J. 16 (1997) 6964-6976
45. Schwartz O., Dautry-Varsat A., Goud B., Marechal V., Subtil A., Heard J.M., and Danos O. Human immunodeficiency virus type 1 Nef induces accumulation of CD4 in early endosomes. J. Virol. 69 (1995) 528-533
46. Piguet V., Chen Y.L., Mangasarian A., Foti M., Carpentier J.L., and Trono D. Mechanism of Nef-induced CD4 endocytosis: Nef connects CD4 with the mu chain of adaptor complexes. EMBO J. 17 (1998) 2472-2481
47. Rossi F., Gallina A., and Milanesi G. Nef-CD4 physical interaction sensed with the yeast two-hybrid system. Virology 217 (1996) 397-403
48. Preusser A., Briese L., Baur A.S., and Willbold D. Direct in vitro binding of full-length human immunodeficiency virus type 1 Nef protein to CD4 cytoplasmic domain. J. Virol. 75 (2001) 3960-3964
49. Harris M.P., and Neil J.C. Myristoylation-dependent binding of HIV-1 Nef to CD4. J. Mol. Biol. 241 (1994) 136-142
50. Preusser A., Briese L., and Willbold D. Presence of a helix in human CD4 cytoplasmic domain promotes binding to HIV-1 Nef protein. Biochem. Biophys. Res. Commun. 292 (2002) 734-740
51. Buonocore L., Turi T.G., Crise B., and Rose J.K. Stimulation of heterologous protein degradation by the Vpu protein of HIV-1 requires the transmembrane and cytoplasmic domains of CD4. Virology 204 (1994) 482-486
52. Raja N.U., Vincent M.J., and Jabbar M.A. Vpu-mediated proteolysis of gp160/CD4 chimeric envelope glycoproteins in the endoplasmic reticulum: requirement of both the anchor and cytoplasmic domains of CD4. Virology 204 (1994) 357-366
53. 13C) nuclear magnetic resonance chemical shifts. J. Am. Chem. Soc. 113 (1991) 5490-5492
54. Post C.B. Exchange-transferred NOE spectroscopy and bound ligand structure determination. Curr. Opin. Struct. Biol. 13 (2003) 581-588
55. Pervushin K., Riek R., Wider G., and Wuthrich K. Attenuated T2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution. Proc. Natl. Acad. Sci. USA 94 (1997) 12366-12371
56. Prosser R.S., Evanics F., Kitevski J.L., and Abdul-Wahid M.S. Current applications of bicelles in NMR studies of membrane-associated amphiphiles and proteins. Biochemistry 45 (2006) 8453-8465